Bertha Coombs
@berthacoombs.cnbc.com
CNBC Senior Health Care Reporter
#RedSoxFan #Chocoholic #HealthcareNerd
https://www.cnbc.com/bertha-coombs/
#RedSoxFan #Chocoholic #HealthcareNerd
https://www.cnbc.com/bertha-coombs/
Insurers mixed. Today is the last day to sign up for ACA coverage starting on Jan 1.
Anecdotal data from eHealth points to more folks trading down to enhanced Bronze plans this year, while state exchange officials say more folks are waiting on pulling the trigger on coverage.
Anecdotal data from eHealth points to more folks trading down to enhanced Bronze plans this year, while state exchange officials say more folks are waiting on pulling the trigger on coverage.
December 15, 2025 at 6:06 PM
Insurers mixed. Today is the last day to sign up for ACA coverage starting on Jan 1.
Anecdotal data from eHealth points to more folks trading down to enhanced Bronze plans this year, while state exchange officials say more folks are waiting on pulling the trigger on coverage.
Anecdotal data from eHealth points to more folks trading down to enhanced Bronze plans this year, while state exchange officials say more folks are waiting on pulling the trigger on coverage.
I think one of the biggest problems is that people don't understand how much the government subsidizes insurance for those of us on employer plans, by excluding taxes on benefits. In 2023 CBO projects it would amount to $5.2 Trillion over 10 years.
December 15, 2025 at 1:54 PM
I think one of the biggest problems is that people don't understand how much the government subsidizes insurance for those of us on employer plans, by excluding taxes on benefits. In 2023 CBO projects it would amount to $5.2 Trillion over 10 years.
Frank Lutz summarizes problem on health care. Says Americans don’t trust Dem’s government solution. GOP proposes insurance market solution, and Americans don’t trust insurers.
So that leaves…🤷🏽♀️
So that leaves…🤷🏽♀️
December 15, 2025 at 11:45 AM
Frank Lutz summarizes problem on health care. Says Americans don’t trust Dem’s government solution. GOP proposes insurance market solution, and Americans don’t trust insurers.
So that leaves…🤷🏽♀️
So that leaves…🤷🏽♀️
Dude, those are some wicked highs on the cannabis stocks...
December 12, 2025 at 4:02 PM
Dude, those are some wicked highs on the cannabis stocks...
I wonder why they chose to cut off Fe-Fe Li in the picture.
December 11, 2025 at 6:52 PM
I wonder why they chose to cut off Fe-Fe Li in the picture.
So, does this mean I could get ChatGPT to speak to me like Moana?
December 11, 2025 at 3:38 PM
So, does this mean I could get ChatGPT to speak to me like Moana?
Here is CVS EVP Prem Shah underscoring that investors should think of the company as a health technology provider.
December 9, 2025 at 4:33 PM
Here is CVS EVP Prem Shah underscoring that investors should think of the company as a health technology provider.
New CVS Tech chief, Tilak Mandadi unveiled the company's new project to integrate care and records in a new platform set to launch next year... that the company says will integrate health records and provide a means of engaging patients to interact with their health care.
December 9, 2025 at 4:31 PM
New CVS Tech chief, Tilak Mandadi unveiled the company's new project to integrate care and records in a new platform set to launch next year... that the company says will integrate health records and provide a means of engaging patients to interact with their health care.
The company talking about integrating all of its services, but CVS Health EVP Prem Shah sets the tone saying the company is in a strong position to be a leader in health tech.
December 9, 2025 at 4:31 PM
The company talking about integrating all of its services, but CVS Health EVP Prem Shah sets the tone saying the company is in a strong position to be a leader in health tech.
CVS shares higher this morning after the health care giant raised 2025 outlook and establishes 2026 guidance in line with expectations.
CEO David Joyner kicked off the company's investor day saying the turnaround momentum will continue.
CEO David Joyner kicked off the company's investor day saying the turnaround momentum will continue.
December 9, 2025 at 4:31 PM
CVS shares higher this morning after the health care giant raised 2025 outlook and establishes 2026 guidance in line with expectations.
CEO David Joyner kicked off the company's investor day saying the turnaround momentum will continue.
CEO David Joyner kicked off the company's investor day saying the turnaround momentum will continue.
This is the “Signature Edition” bible.
December 5, 2025 at 4:56 PM
This is the “Signature Edition” bible.
This post is pinned to Senator Cassidy's X profile.
December 5, 2025 at 4:27 PM
This post is pinned to Senator Cassidy's X profile.
Senator Cassidy: "Acting CDC Director O’Neill should not sign these new recommendations and instead retain the current, evidence-based approach."
December 5, 2025 at 4:24 PM
Senator Cassidy: "Acting CDC Director O’Neill should not sign these new recommendations and instead retain the current, evidence-based approach."
Shares of GSK are now down 1%.
December 5, 2025 at 4:14 PM
Shares of GSK are now down 1%.
December 5, 2025 at 2:43 PM
New ACIP board member Retsef Levi says parents should ask themselves about the real need for the Hep B vaccine, given how rare cases are in babies. So, it would seem by the same logic, that they shouldn't avoid Covid shots because of rare instances of bad outcomes in kids?
December 5, 2025 at 1:45 PM
New ACIP board member Retsef Levi says parents should ask themselves about the real need for the Hep B vaccine, given how rare cases are in babies. So, it would seem by the same logic, that they shouldn't avoid Covid shots because of rare instances of bad outcomes in kids?
@kff.org poll: "Majorities across partisanship want to extend the enhanced premium tax credits, including nearly all Democrats (95%), about eight in ten independents (84%), and about seven in ten Republicans (72%) enrolled in Marketplace plans."
www.kff.org/public-opini...
www.kff.org/public-opini...
December 4, 2025 at 6:04 PM
@kff.org poll: "Majorities across partisanship want to extend the enhanced premium tax credits, including nearly all Democrats (95%), about eight in ten independents (84%), and about seven in ten Republicans (72%) enrolled in Marketplace plans."
www.kff.org/public-opini...
www.kff.org/public-opini...
Open Enrollment ends December 15th for most ACA enrollees. Still no deal in sight on tax credits in DC.
December 4, 2025 at 11:30 AM
Open Enrollment ends December 15th for most ACA enrollees. Still no deal in sight on tax credits in DC.
For folks who have relied on enhanced tax credits, the 2026 deadline on healthcare.gov looms like the anti-Advent... with no deal sight from Washington.
Policy folks advise signing up; there could be a deal after the deadline. if there isn't, you could drop out after using your annual exam.
Policy folks advise signing up; there could be a deal after the deadline. if there isn't, you could drop out after using your annual exam.
December 3, 2025 at 3:35 PM
For folks who have relied on enhanced tax credits, the 2026 deadline on healthcare.gov looms like the anti-Advent... with no deal sight from Washington.
Policy folks advise signing up; there could be a deal after the deadline. if there isn't, you could drop out after using your annual exam.
Policy folks advise signing up; there could be a deal after the deadline. if there isn't, you could drop out after using your annual exam.
WITH 14 DAYS LEFT UNTIL the OPEN ENROLLMENT DEADLINE on healthcare.gov... spoke with an ACA insurance exec who says they haven't heard anything new on a possible resolution to the enhanced tax credit standoff in Washington.
December 2, 2025 at 5:24 PM
WITH 14 DAYS LEFT UNTIL the OPEN ENROLLMENT DEADLINE on healthcare.gov... spoke with an ACA insurance exec who says they haven't heard anything new on a possible resolution to the enhanced tax credit standoff in Washington.
WH Econ Adv. Kevin Hassett says there will be an ACA deal: "What we're going to see.. between now and Christmas, is that people are going to work this out.. The White House has a solution for cost sharing, and the Democrats have an alternative."
Meantime people face a DEC. 15TH DEADLINE to enroll.
Meantime people face a DEC. 15TH DEADLINE to enroll.
December 1, 2025 at 12:40 AM
WH Econ Adv. Kevin Hassett says there will be an ACA deal: "What we're going to see.. between now and Christmas, is that people are going to work this out.. The White House has a solution for cost sharing, and the Democrats have an alternative."
Meantime people face a DEC. 15TH DEADLINE to enroll.
Meantime people face a DEC. 15TH DEADLINE to enroll.
When I worked at WABC I walked outside at 7 am to meet my crew to cover the parade. New Yorkers who’d camped out wouldn’t let me through at first, saying I should have gotten there earlier. They relented when I pointed out I’d been working since 3 a.m. and had anchored a show! 😂
#NYCThanksgiving🦃
#NYCThanksgiving🦃
November 27, 2025 at 2:46 PM
When I worked at WABC I walked outside at 7 am to meet my crew to cover the parade. New Yorkers who’d camped out wouldn’t let me through at first, saying I should have gotten there earlier. They relented when I pointed out I’d been working since 3 a.m. and had anchored a show! 😂
#NYCThanksgiving🦃
#NYCThanksgiving🦃
The government's ability to negotiate drug prices stands in stark contrast right now to the inability to control health insurance costs. 2026 prices have spiked due to higher utilization and subsidy uncertainty. And there's no deal yet on the latter with 19 days until open enrollment ends for most.
November 26, 2025 at 12:22 PM
The government's ability to negotiate drug prices stands in stark contrast right now to the inability to control health insurance costs. 2026 prices have spiked due to higher utilization and subsidy uncertainty. And there's no deal yet on the latter with 19 days until open enrollment ends for most.
The discounts for Abbvy's Linzess and Salix Pharma's Xifaxan are 75% and 63% below list, respectively. Though the price for Xifaxan is about the same as the CMS gross price in 2024. (5/5)
November 26, 2025 at 3:12 AM
The discounts for Abbvy's Linzess and Salix Pharma's Xifaxan are 75% and 63% below list, respectively. Though the price for Xifaxan is about the same as the CMS gross price in 2024. (5/5)
GSK's COPD inhaler Trelegy Ellipta's IRA price of $175 is about in line with prices in Canada, while the price for the two-drug version Breo Ellipta at $67 is about 1/3 the price in Canada. (4/5)
November 26, 2025 at 3:12 AM
GSK's COPD inhaler Trelegy Ellipta's IRA price of $175 is about in line with prices in Canada, while the price for the two-drug version Breo Ellipta at $67 is about 1/3 the price in Canada. (4/5)